Literature DB >> 25499035

Effects of subcallosal cingulate deep brain stimulation on negative self-bias in patients with treatment-resistant depression.

Matthew R Hilimire1, Helen S Mayberg2, Paul E Holtzheimer3, James M Broadway4, Nathan A Parks5, Jordan E DeVylder6, Paul M Corballis7.   

Abstract

BACKGROUND: The cognitive neuropsychological model states that antidepressant treatment alters emotional biases early in treatment, and after this initial change in emotional processing, environmental and social interactions allow for long-term/sustained changes in mood and behavior.
OBJECTIVE: Changes in negative self-bias after chronic subcallosal cingulate (SCC) deep brain stimulation (DBS) were investigated with the hypothesis that treatment would lead to changes in emotional biases followed by changes in symptom severity.
METHODS: Patients (N = 7) with treatment-resistant depression were assessed at three time points: pre-treatment; after one month stimulation; and after six months stimulation. The P1, P2, P3, and LPP (late positive potential) components of the event-related potential elicited by positive and negative trait adjectives were recorded in both a self-referential task and a general emotion recognition task.
RESULTS: Results indicate that DBS reduced automatic attentional bias toward negative words early in treatment, as indexed by the P1 component, and controlled processing of negative words later in treatment, as indexed by the P3 component. Reduction in negative words endorsed as self-descriptive after six months DBS was associated with reduced depression severity after six months DBS. Change in emotional processing may be restricted to the self-referential task.
CONCLUSIONS: Together, these results suggest that the cognitive neuropsychological model, developed to explain the time-course of monoamine antidepressant treatment, may also be used as a framework to interpret the antidepressant effects of SCC DBS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brodmann area 25; Electrical stimulation; Electroencephalography; Event-related potentials; Mood disorders; Subgenual cingulate

Mesh:

Year:  2014        PMID: 25499035      PMCID: PMC4366934          DOI: 10.1016/j.brs.2014.11.010

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  46 in total

1.  Dorsolateral prefrontal cortex stimulation modulates electrocortical measures of visual attention: evidence from direct bilateral epidural cortical stimulation in treatment-resistant mood disorder.

Authors:  G Hajcak; B S Anderson; A Arana; J Borckardt; I Takacs; M S George; Z Nahas
Journal:  Neuroscience       Date:  2010-05-06       Impact factor: 3.590

Review 2.  Medial prefrontal cortex and the self in major depression.

Authors:  Cédric Lemogne; Pauline Delaveau; Maxime Freton; Sophie Guionnet; Philippe Fossati
Journal:  J Affect Disord       Date:  2010-12-23       Impact factor: 4.839

3.  Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years.

Authors:  Sidney H Kennedy; Peter Giacobbe; Sakina J Rizvi; Franca M Placenza; Yasunori Nishikawa; Helen S Mayberg; Andres M Lozano
Journal:  Am J Psychiatry       Date:  2011-02-01       Impact factor: 18.112

Review 4.  Neural mechanisms of the cognitive model of depression.

Authors:  Seth G Disner; Christopher G Beevers; Emily A P Haigh; Aaron T Beck
Journal:  Nat Rev Neurosci       Date:  2011-07-06       Impact factor: 34.870

5.  Automatic and strategic representation of the self in major depression: trait and state abnormalities.

Authors:  Avgusta Y Shestyuk; Patricia J Deldin
Journal:  Am J Psychiatry       Date:  2010-04-01       Impact factor: 18.112

6.  A prefrontal cortex-brainstem neuronal projection that controls response to behavioural challenge.

Authors:  Melissa R Warden; Aslihan Selimbeyoglu; Julie J Mirzabekov; Maisie Lo; Kimberly R Thompson; Sung-Yon Kim; Avishek Adhikari; Kay M Tye; Loren M Frank; Karl Deisseroth
Journal:  Nature       Date:  2012-12-20       Impact factor: 49.962

Review 7.  Cognition and depression: current status and future directions.

Authors:  Ian H Gotlib; Jutta Joormann
Journal:  Annu Rev Clin Psychol       Date:  2010       Impact factor: 18.561

8.  Neural substrate of the late positive potential in emotional processing.

Authors:  Yuelu Liu; Haiqing Huang; Menton McGinnis-Deweese; Andreas Keil; Mingzhou Ding
Journal:  J Neurosci       Date:  2012-10-17       Impact factor: 6.167

9.  Self-referential processing and the prefrontal cortex over the course of depression: a pilot study.

Authors:  Cédric Lemogne; Helen Mayberg; Loretxu Bergouignan; Emmanuelle Volle; Pauline Delaveau; Stéphane Lehéricy; Jean-François Allilaire; Philippe Fossati
Journal:  J Affect Disord       Date:  2009-11-27       Impact factor: 4.839

10.  Rostral anterior cingulate cortex activity mediates the relationship between the depressive symptoms and the medial prefrontal cortex activity.

Authors:  Shinpei Yoshimura; Yasumasa Okamoto; Keiichi Onoda; Miki Matsunaga; Kazutaka Ueda; Shin-ichi Suzuki
Journal:  J Affect Disord       Date:  2009-07-09       Impact factor: 4.839

View more
  17 in total

1.  Principal components of electrocortical activity during self-evaluation indicate depressive symptom severity.

Authors:  Allison C Waters; Don M Tucker
Journal:  Soc Cogn Affect Neurosci       Date:  2016-04-06       Impact factor: 3.436

2.  Field potential 1/f activity in the subcallosal cingulate region as a candidate signal for monitoring deep brain stimulation for treatment-resistant depression.

Authors:  Ashan Veerakumar; Vineet Tiruvadi; Bryan Howell; Allison C Waters; Andrea L Crowell; Bradley Voytek; Patricio Riva-Posse; Lydia Denison; Justin K Rajendra; Johnathan A Edwards; Kelly R Bijanki; Ki Sueng Choi; Helen S Mayberg
Journal:  J Neurophysiol       Date:  2019-07-17       Impact factor: 2.714

3.  White matter abnormalities predict residual negative self-referential thinking following treatment of late-life depression with escitalopram: A preliminary study.

Authors:  Lindsay W Victoria; George S Alexopoulos; Irena Ilieva; Aliza T Stein; Matthew J Hoptman; Naib Chowdhury; Matteo Respino; Sarah Shizuko Morimoto; Dora Kanellopoulos; Jimmy N Avari; Faith M Gunning
Journal:  J Affect Disord       Date:  2018-09-11       Impact factor: 4.839

Review 4.  Multimodal approaches to define network oscillations in depression.

Authors:  Otis Lkuwamy Smart; Vineet Ravi Tiruvadi; Helen S Mayberg
Journal:  Biol Psychiatry       Date:  2015-01-28       Impact factor: 13.382

Review 5.  Precision psychiatry: a neural circuit taxonomy for depression and anxiety.

Authors:  Leanne M Williams
Journal:  Lancet Psychiatry       Date:  2016-04-14       Impact factor: 27.083

Review 6.  Top-Down Control of Serotonin Systems by the Prefrontal Cortex: A Path toward Restored Socioemotional Function in Depression.

Authors:  Collin Challis; Olivier Berton
Journal:  ACS Chem Neurosci       Date:  2015-03-17       Impact factor: 4.418

7.  Improving late life depression and cognitive control through the use of therapeutic video game technology: A proof-of-concept randomized trial.

Authors:  Joaquin A Anguera; Faith M Gunning; Patricia A Areán
Journal:  Depress Anxiety       Date:  2017-01-03       Impact factor: 6.505

Review 8.  Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications.

Authors:  M P Dandekar; A J Fenoy; A F Carvalho; J C Soares; J Quevedo
Journal:  Mol Psychiatry       Date:  2018-02-27       Impact factor: 15.992

Review 9.  A neurocognitive model for understanding treatment action in depression.

Authors:  Matthew B Warren; Abbie Pringle; Catherine J Harmer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

Review 10.  Brain-based mechanisms of late-life depression: Implications for novel interventions.

Authors:  Faith M Gunning; Lauren E Oberlin; Maddy Schier; Lindsay W Victoria
Journal:  Semin Cell Dev Biol       Date:  2021-05-12       Impact factor: 7.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.